Clinical trial • Phase III • Psychiatry
Clinical trial in Attention deficit hyperactivity disorder | Borderline personality disorder
Phase III trial for Attention deficit hyperactivity disorder | Borderline personality disorder. 68 participants.
Overview
- Trial Therapeutic Area
- Psychiatry
- Trial Disease
- Attention deficit hyperactivity disorder | Borderline personality disorder
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 20-12-2024
- First CTIS Authorization Date
- 13-03-2025
Trial design
Phase III trial across 12 sites in Germany.
- Target Sample Size
- 68
- Trial Duration For Participant
- 569
Recruitment
- Planned Sample Size
- 68
- Recruitment Window Months
- 18
Geography
- Total Number Of Sites
- 12
- Total Number Of Participants
- 68
Germany
- Earliest CTIS Part Ii Submission Date
- 24-02-2025
- Latest Decision Or Authorization Date
- 15-05-2026
- Processing Time Days
- 445
- Number Of Sites
- 12
- Number Of Participants
- 68
Sites
- Site Name
- Medizinische Hochschule Hannover
- Department Name
- Fraunhofer-Institut für Toxikologie und Experimentelle Medizin
- Contact Person Name
- Philipp Badorrek
- Contact Person Email
- philipp.badorrek@item.fraunhofer.de
- Site Name
- Technische Universitaet Dresden
- Department Name
- Klinik und Poliklinik für Psychiatrie und Psychotherapie
- Contact Person Name
- Philipp Ritter
- Contact Person Email
- philipp.ritter@ukdd.de
- Site Name
- Universitaet Leipzig
- Department Name
- Klinik und Poliklinik für Psychiatrie und Psychotherapie
- Contact Person Name
- Maria Strauss
- Contact Person Email
- Maria.Strauss@medizin.uni-leipzig.de
- Site Name
- Zentrum Fuer Integrative Psychiatrie ZIP gGmbH Praevention-Therapie-Rehabilitation
- Department Name
- Praevention-Therapie-Rehabilitation
- Contact Person Name
- Ingolf Cascorbi
- Contact Person Email
- cascorbi@pharmakologie.uni-kiel.de
- Site Name
- University Medical Center Hamburg-Eppendorf
- Department Name
- Klinik und Poliklinik für Psychiatrie und Psychotherapie
- Contact Person Name
- Jürgen Gallinat
- Contact Person Email
- j.gallinat@uke.de
- Site Name
- Charite Research Organisation GmbH
- Department Name
- Charité - Universitätsmedizin Berlin
- Contact Person Name
- Christian Keicher
- Contact Person Email
- christian.keicher@charite-research.org
- Site Name
- Zentralinstitut Fuer Seelische Gesundheit
- Department Name
- Klinik für Psychosomatik
- Contact Person Name
- Christian Schmahl
- Contact Person Email
- christian.schmahl@zi-mannheim.de
- Site Name
- Martin-Luther-Universitaet Halle-Wittenberg
- Department Name
- Psychotherapie und Psychosomatik
- Contact Person Name
- Oliver Tüscher
- Contact Person Email
- oliver.tuescher@uk-halle.de
- Site Name
- Universitaetsklinikum Tuebingen AöR
- Department Name
- Klinik für Psychiatrie und Psychotherapie
- Contact Person Name
- Thomas Ethofer
- Contact Person Email
- thomas.ethofer@med.uni-tuebingen.de
- Site Name
- Universitaetsklinikum Bonn AöR
- Department Name
- Klinik und Poliklinik für Psychiatrie und Psychotherapie
- Contact Person Name
- Alexandra Philipsen
- Contact Person Email
- alexandra.philipsen@ukbonn.de
- Site Name
- Rheinhessen-Fachklinik Mainz
- Department Name
- Abteilung für Kinder- und Jugendpsychiatrie
- Contact Person Name
- Michael Huss
- Contact Person Email
- m.huss@rfk.landeskrankenhaus.de
- Site Name
- Goethe University Frankfurt
- Department Name
- Klinik für Psychiatrie, Psychosomatik und Psychotherapie
- Contact Person Name
- Oliver Grimm
- Contact Person Email
- O.Grimm@med.uni-frankfurt.de
Sponsor
Primary sponsor
- Full Name
- Boehringer Ingelheim International GmbH
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Germany
Related trials
Other published trials that may interest you.